Asian Pacific Journal of Cancer Prevention

  • 제17권3호
  • /
  • Pages.1411-1414
  • /
  • 2016
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Eosinophilia in Pleural Effusions: a Speculative Negative Predictor for Malignancy

  • Chu, Fang-Yeh (Department of Clinical Pathology, Far Eastern Memorial Hospital) ;
  • Liou, Ching-Biau (Department of Clinical Pathology, Far Eastern Memorial Hospital) ;
  • Sun, Jen-Tang (Department of Emergency, Far Eastern Memorial Hospital) ;
  • Bei, Chia-Hao (Department of Clinical Pathology, Far Eastern Memorial Hospital) ;
  • Liou, Tse-Hsuan (Department of Clinical Pathology, Far Eastern Memorial Hospital) ;
  • Tan, N-Chi (Department of Clinical Pathology, Far Eastern Memorial Hospital) ;
  • Yu, Yun-Chieh (Division of Nephrology and Clinical Toxicology, Chang Gung Memorial Hospital, Lin-Kou Medical Center) ;
  • Chang, Chih-Chun (Department of Clinical Pathology, Far Eastern Memorial Hospital) ;
  • Yen, Tzung-Hai (Department of Clinical Pathology, Far Eastern Memorial Hospital) ;
  • Su, Ming-Jang (Department of Clinical Pathology, Far Eastern Memorial Hospital)
  • 발행 : 2016.04.11
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Eosinophilic pleural effusion (EPE) is an eosinophil count more than 10% on cytology of pleural samples. Recently, it was reported that malignancy had been the most prevalent cause inducing EPE. Therefore, we conducted an analysis on the prevalence and etiology of EPE and investigated the relationship between EPE and malignancy. Materials and Methods: Data for pleural cell differential count from patients receiving thoracentesis during the period from January 2008 to December 2013 were compared with clinical data and established diagnosis of patients obtained via electronic chart review. Results: A total of 6,801 requests of pleural cytology from 3,942 patients with pleural effusion who had received thoracentesis were available at Far Eastern Memorial Hospital from 2008 to 2013, and of these subjects, 115 (2.9%) were found to have EPE. The most frequent cause of EPE was malignancy (33.0%, n=38), followed by parapneumonic effusions (27.8%, n=32), tuberculosis pleuritis (13.9%, n=16), transudate effusions (12.2%, n=14) and the presence of blood or air in pleural space (10.4%, n=12). Additionally, an inverse relationship of eosinophilia in pleural fluid was identified in patients with malignancy and EPE. The cut-off eosinophil count in pleural fluid was 15% for the most accurate discrimination between malignancy and benign disorders in patients with EPE. At the cut-off level, the sensitivity and specificity were 65.8% and 67.5%, respectively. Conclusions: Pleural fluid eosinophilia was a speculative negative predictor for malignancy, despite the fact that cancers, including lung cancers and metastatic cancers to lung, were the most leading cause of pleural fluid eosinophilia. An inverse correlation was observed between the pleural eosinophil percentage and the likelihood of malignancy in patients with EPE.

키워드

참고문헌

  1. Adelman M, Albelda SM, Gottlieb J, et al (1984). Diagnostic utility of pleural fluid eosinophilia. Am J Med, 77, 915-20. https://doi.org/10.1016/0002-9343(84)90542-4
  2. Chung CL, Chen YC, Chang SC (2003). Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest, 123, 1188-95. https://doi.org/10.1378/chest.123.4.1188
  3. Evison M, Holme J, Alaloul M, et al (2014). Olanzapine-induced eosinophilic pleuritis. Respir Med Case Rep, 14, 24-6.
  4. Heidecker J, Kaplan A, Sahn SA (2006). Pleural fluid and peripheral eosinophilia from hemothorax: hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. Am J Med Sci, 332, 148-52. https://doi.org/10.1097/00000441-200609000-00011
  5. Kalomenidis I, Light RW (2003). Eosinophilic pleural effusions. Curr Opin Pulm Med, 9, 254-60. https://doi.org/10.1097/00063198-200307000-00002
  6. Kalomenidis I, Light RW (2004). Pathogenesis of the eosinophilic pleural effusions. Curr Opin Pulm Med, 10, 289-93. https://doi.org/10.1097/01.mcp.0000127902.37822.13
  7. Kalomenidis I, Stathopoulos GT, Barnette R, et al (2005). Eotaxin-3 and interleukin-5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions. Chest, 127, 2094-100. https://doi.org/10.1378/chest.127.6.2094
  8. Kim E, Kim C, Yang B, et al (2013). Intrapleural corticosteroid injection in eosinophilic pleural effusion associated with undifferentiated connective tissue disease. Tuberc Respir Dis (Seoul), 75, 161-4. https://doi.org/10.4046/trd.2013.75.4.161
  9. Krenke R, Nasilowski J, Korczynski P, et al (2009). Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J, 34, 1111-7. https://doi.org/10.1183/09031936.00197708
  10. Krenke R, Light RW (2011). Drug-induced eosinophilic pleural effusion. Eur Respir Rev, 20, 300-1. https://doi.org/10.1183/09059180.00005811
  11. Kwon BI, Hong S, Shin K, et al (2013). Innate type 2 immunity is associated with eosinophilic pleural effusion in primary spontaneous pneumothorax. Am J Respir Crit Care Med, 188, 577-85. https://doi.org/10.1164/rccm.201302-0295OC
  12. Lin SS, Chen YC, Chang YL, et al (2014). Crystal amphetamine smoking-induced acute eosinophilic pneumonia and diffuse alveolar damage: a case report and literature review. Chin J Physiol, 57, 295-8. https://doi.org/10.4077/CJP.2014.BAC201
  13. Lin Q, Ouyang JS, Li JM, et al (2015). Eosinophilic pleural effusion due to Spirometra mansoni spargana: a case report and review of the literature. Int J Infect Dis, 34, 96-8. https://doi.org/10.1016/j.ijid.2015.03.014
  14. Mohamed KH, Abdelhamid AI, Lee YC, et al (2002). Pleural fluid levels of interleukin-5 and eosinophils are closely correlated. Chest, 122, 576-80. https://doi.org/10.1378/chest.122.2.576
  15. Nakamura Y, Ozaki T, Kamei T, et al (1993). Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocyte/macrophage colony-stimulating factor, interleukin-5, and interleukin-3. Am J Respir Cell Mol Biol, 8, 605-11. https://doi.org/10.1165/ajrcmb/8.6.605
  16. Oba Y, Abu-Salah T (2012). The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration, 83, 198-208. https://doi.org/10.1159/000327200
  17. Oh Y, Kim JT, Kim MK, et al (2014). Eosinophilic pleuritis due to sparganum: a case report. Korean J Parasitol, 52, 541-3. https://doi.org/10.3347/kjp.2014.52.5.541
  18. Ozkara SK, Turan G, Basyigit I (2007). Clinicopathologic significance of eosinophilic pleural effusions in a population with a high prevalence of tuberculosis and cancer. Acta Cytol, 51, 773-81. https://doi.org/10.1159/000325841
  19. Rubins JB, Rubins HB (1996). Etiology and prognostic significance of eosinophilic pleural effusions. A prospective study. Chest, 110, 1271-4. https://doi.org/10.1378/chest.110.5.1271
  20. Strong DH, Westcott JY, Biller JA, et al (2003). Eosinophilic "empyema" associated with crack cocaine use. Thorax, 58, 823-4. https://doi.org/10.1136/thorax.58.9.823
  21. Wysenbeek AJ, Lahav M, Aelion JA, et al (1985). Eosinophilic pleural effusion: a review of 36 cases. Respiration, 48, 73-6. https://doi.org/10.1159/000194802